Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Melanoma

dichlororibofuranosylbenzimidazole has been researched along with Melanoma in 2 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourcier, C1
Griseri, P1
Grépin, R1
Bertolotto, C1
Mazure, N1
Pagès, G1
Blaydes, JP1
Craig, AL1
Wallace, M1
Ball, HM1
Traynor, NJ1
Gibbs, NK1
Hupp, TR1

Other Studies

2 other studies available for dichlororibofuranosylbenzimidazole and Melanoma

ArticleYear
Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
    American journal of physiology. Cell physiology, 2011, Volume: 301, Issue:3

    Topics: Animals; Antibodies; Antineoplastic Agents; Apoptosis; Autophagy; Benzamides; Benzenesulfonates; Cel

2011
Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways.
    Oncogene, 2000, Aug-10, Volume: 19, Issue:34

    Topics: Amino Acid Sequence; Cyclin-Dependent Kinases; Dichlororibofuranosylbenzimidazole; DNA Damage; Enzym

2000